Insider Trading & Ownership - Zentalis Pharmaceuticals Inc. (ZNTL)

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Zentalis Pharmaceuticals Inc.
Goto Prev, 0, 1, 2, 3, 4, 5
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2020-12-01
Sale
2020-12-03
5:57 pm
Zentalis Pharmaceuticals Inc. ZNTL Bunker Kevin D.
Chief Operating Officer
8,420 $52.96 $445,883 1,161,137
(Indirect
Direct)
View
2020-12-02
Sale
2020-12-03
5:56 pm
Zentalis Pharmaceuticals Inc. ZNTL Gallagher Cam
Director
10,000 $51.43 $514,334 635,404
(Indirect
Direct)
View
2020-12-02
Sale
2020-12-03
5:56 pm
Zentalis Pharmaceuticals Inc. ZNTL SUN ANTHONY Y
President & CEO
26,794 $51.4 $1,377,344 3,067,282
(Indirect
Direct)
View
2020-12-02
Sale
2020-12-03
5:56 pm
Zentalis Pharmaceuticals Inc. ZNTL Epperly Melissa B
Chief Financial Officer
3,083 $51.47 $158,681 291,363
(Direct)
View
2020-11-23
Sale
2020-11-25
8:33 pm
Zentalis Pharmaceuticals Inc. ZNTL Gallagher Cam
Director
10,000 $46.54 $465,381 645,404
(Indirect
Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2020-10-28
Other
2020-10-30
7:53 pm
N/A
N/A
Zentalis Pharmaceuticals Inc. ZNTL Recurium Equity LLC
10% Owner
4,147,940 $0 4,162,930
(Direct)
View
2020-08-31
Option Award
2020-09-01
9:16 pm
N/A
2030-08-30
Zentalis Pharmaceuticals Inc. ZNTL Pinto Alexis
Chief Legal Officer
275,000 $0 275,000
(Direct)
View
Goto Prev, 0, 1, 2, 3, 4, 5